Teva Wins Court Ruling Against Opiant, Emergent Bio On Narcan Nasal Spray
Citi slashes Teva price target - Globes
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Gets a Quantitative Upgrade to Hold - RealMoney
Teva Pharmaceutical Industries (NYSE:TEVA) Upgraded to "Outperform" by Sanford C. Bernstein | MarketBeat
Teva bails on price-fixing settlement in gamble on its role fighting COVID-19: report | Fierce Pharma
Teva Pharmaceutical Industries (NYSE:TEVA) - Share price, News & Analysis - Simply Wall St
/TEVA-Chart-02142019-5c65830bc9e77c0001d93394.png "Where Are Teva Shares Headed After the Q4 Decline?")
Where Are Teva Shares Headed After the Q4 Decline?
Teva Pharmaceutical Industries Price Target & Analyst Ratings (NYSE:TEVA)
Teva Pharmaceutical Industries Stock Forecast: up to 474.189 USD! - TEVVF Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis
Teva Pharmaceutical Industries Stock Forecast: up to 474.189 USD! - TEVVF Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis
Drug Stock Due for Another Climb on the Charts
Teva's Rallying Shares Look Fully Valued | Barron's
I See No Technical Reason to Approach Teva Pharmaceuticals From the Long Side - RealMoney
Teva Stock Offers Maximum Optimism For Investors (NYSE:TEVA) | Seeking Alpha
Analysts see upside in Teva share price - Globes
/TEVA-Chart-06032019-bae8191f63b145ac80c5d08764666366.png "Teva Pharmaceutical Gets Reprieve After Analyst Upgrade")
Teva Pharmaceutical Gets Reprieve After Analyst Upgrade
:max_bytes(150000):strip_icc()/TEVA-Chart-06032019-bae8191f63b145ac80c5d08764666366.png "Teva Pharmaceutical Gets Reprieve After Analyst Upgrade")
Teva Pharmaceutical Gets Reprieve After Analyst Upgrade
Teva to be First Target in Generic Price-Fixing Suit – Policy & Medicine
Teva Pharmaceutical Gets a Quantitative Upgrade to Hold - RealMoney
Teva Picked as Bellwether Target in Generic Drug Price-Fix Case
Teva Pharmaceutical Indus (NYSE:TEVA), Quotes and News Summary - Benzinga
Teva Pharmaceutical Stock Could Double | Barron's
